Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
Clinical trial NCT00697229 · COMPLETED
Trial details
- NCT number
- NCT00697229
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1992-09-01
- Primary completion
- 1996-05-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.